High hsCRP may up risk of macular edema in T1DM

February 8, 2013
High hsCRP may up risk of macular edema in T1DM
For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein are associated with an increased risk of clinically significant macular edema and with the development of retinal hard exudates, according to a study published online Feb. 7 in JAMA Ophthalmology.

(HealthDay)—For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with an increased risk of clinically significant macular edema (CSME) and with the development of retinal hard exudates, according to a study published online Feb. 7 in JAMA Ophthalmology.

In a large multicenter randomized trial (Diabetes Control and Complications Trial [DCCT]), Rajeev H. Muni, M.D., from St. Michael's Hospital and the Hospital for Sick Children in Toronto, and colleagues examined whether baseline hsCRP and intercellular adhesion molecule 1 (ICAM-1) levels predict the development and progression of , CSME, and retinal hard exudates. The study population included 1,441 subjects with .

After adjustment for randomized treatment assignment and additional variables, the researchers identified an association between hsCRP and the risk of CSME (relative risk, 1.83 for highest versus lowest quintile; 95 percent confidence interval [CI], 0.94 to 3.55) and for the development of retinal hard exudates (relative risk, 1.78 for highest versus lowest quintile; 95 percent CI, 0.98 to 3.25). For ICAM-1, the relative risk of developing retinal hard exudates was 1.50 for the highest versus lowest quintile (95 percent CI, 0.84 to 2.68).

"After adjusting for known risk factors, increasing quintiles of baseline level may be associated with higher risk of incident CSME and macular hard exudate in the DCCT cohort," the authors write.

Explore further: Microaneurysm turnover IDs macular edema development

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Microaneurysm turnover IDs macular edema development

January 8, 2013
(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to a study published ...

Findings support link between hsCRP, macular degeneration

February 8, 2013
(HealthDay)—Pooled results from five cohorts confirm that high levels of high-sensitivity C-reactive protein (hsCRP) correlate with increased future risk of age-related macular degeneration (AMD), according to research ...

Clopidogrel after MI less effective in diabetes patients

September 5, 2012
(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue of the Journal ...

Low HDL cholesterol ups risk of diabetic nephropathy

August 22, 2012
(HealthDay) -- High-density lipoprotein cholesterol (HDL-C) is an independent risk factor for the development of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes, according to research published ...

Study reports two-year outcomes of diabetic macular edema treatment

April 9, 2012
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that ...

Early menopause tied to greater type 2 diabetes risk

December 27, 2012
(HealthDay)—Women who experience early menopause have a greater risk of type 2 diabetes, according to a study published online Dec. 10 in Diabetes Care.

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.